Breast Cancer Treatment Options And Outcomes - resource for patients

Find out how the different therapies can benefit your disease management. Breast cancer treatments generally include surgical removal of the cancerous tissue, chemotherapy, radiation therapy, immunotherapy and hormone blocking therapies. There are 39 FDA-approved breast cancer drugs. Immunotherapy drugs such as pembrolizumab in combination with chemotherapy can increase the progression free survival in TNBC patients for 4 months over chemotherapy alone. Metastatic breast cancer patients who take tamoxifen have a 66% chance of surviving 10-years. Addition of radiation with tamoxifen increases that chance to 67%. Metastatic breast cancer patients treated with capecitabine (Xeloda) shows a median overall survival of 14.5 months. Patients with invasive breast cancer treated with docetaxel and cyclophosphamide shows a 5-year disease-free suvival rate of 86%. There are 6 different combinations approved to treat different stages of breast cancer. All these information and much more can be found in this report.